This topic contains a solution. Click here to go to the answer

Author Question: An infant with cancer is to receive vincristine (Oncovin) 0.05 mg/kg intravenously. The infant ... (Read 77 times)

jhjkgdfhk

  • Hero Member
  • *****
  • Posts: 569
An infant with cancer is to receive vincristine (Oncovin) 0.05 mg/kg intravenously. The infant weighs 18 lb. What is the appropriate dose, in mg?
 
  What is the answer?

Question 2

A patient receiving hormone manipulation as cancer therapy has all of the following side effects. For which one should you notify the prescriber immediately?
 
  a. Redness, pain, and swelling of the calf
  b. Fluid retention with weight gain
  c. Acne and darkening of the skin
  d. Breast swelling and tenderness



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

juwms

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

0.409

Answer to Question 2

ANS: A




jhjkgdfhk

  • Member
  • Posts: 569
Reply 2 on: Jul 23, 2018
:D TYSM


lindahyatt42

  • Member
  • Posts: 322
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

Complications of influenza include: bacterial pneumonia, ear and sinus infections, dehydration, and worsening of chronic conditions such as asthma, congestive heart failure, or diabetes.

Did you know?

Patients who cannot swallow may receive nutrition via a parenteral route—usually, a catheter is inserted through the chest into a large vein going into the heart.

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

Did you know?

Patients who have undergone chemotherapy for the treatment of cancer often complain of a lack of mental focus; memory loss; and a general diminution in abilities such as multitasking, attention span, and general mental agility.

For a complete list of videos, visit our video library